Impact of exogenous hyperglucagonemia on postprandial concentrations of gastric inhibitory polypeptide and glucagon-like peptide-1 in humans

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 8, 2010, Pages 4061-4065

  Meier, Juris J ^a   Ritter, Peter R ^a   Jacob, Alexandra ^a   Menge, Bjoern A ^a   Deacon, Carolyn F ^b   Schmidt, Wolfgang E ^a   Nauck, Michael A ^c   Holst, Jens J ^b  

^a ST JOSEF HOSPITAL   (Germany)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c DIABETESZENTRUM BAD LAUTERBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INSULIN; MEGLITINIDE; METFORMIN; PLACEBO; RECOMBINANT GLUCAGON; ROSIGLITAZONE; SULFONYLUREA;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG WITHDRAWAL; FEMALE; GLUCOSE BLOOD LEVEL; HORMONE BLOOD LEVEL; HUMAN; HYPERGLUCAGONEMIA; INGESTION; INSULIN BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STOMACH EMPTYING; TREATMENT WITHDRAWAL;

EID: 77955401792     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0550     Document Type: Article

References (11)

1. Vilsbøll T, Krarup T, Deacon CF, Madsbad S, Holst JJ 2001 Reduced postprandial concentrations of intact biologically active glucagon-like peptide 1 in type 2 diabetic patients. Diabetes 50: 609-613 (Pubitemid 32195226)
2. Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ 2001 Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86:3717-3723 (Pubitemid 32755966)
3. Vollmer K, Holst JJ, Baller B, Ellrichmann M, Nauck MA, Schmidt WE, Meier JJ 2008 Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance. Diabetes 57: 678-687
4. Ryskjaer J, Deacon CF, Carr RD, Krarup T, Madsbad S, Holst J, Vilsboll T 2006 Plasma dipeptidyl peptidase-IV activity in patients with type 2 diabetes mellitus correlates positively with HbAlc levels, but is not acutely affected by food intake. Eur J Endocrinol 155: 485-493 (Pubitemid 44463956)
5. Meier JJ, Nauck MA 2008 Is secretion of glucagon-like peptide-1 reduced in type 2 diabetes mellitus? Nat Clin Pract Endocrinol Metab 4:606-607
6. Meier JJ, Gallwitz B, Salmen S, Goetze O, Holst JJ, Schmidt WE, Nauck MA 2003 Normalization of glucose concentrations and deceleration of gastric emptying after solid meals during intravenous glucagon-like peptide 1 in patients with type 2 diabetes. J Clin Endocrinol Metab 88:2719-2725 (Pubitemid 36733545)
7. Ranganath L, Schaper F, Gama R, Morgan L, Wright J, Teale D, Marks V 1999 Effect of glucagon on carbohydrate-mediated secretion of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (7-36 amide) (GLP-1). Diabetes Metab Res Rev 15:390-394
8. Lefèbvre PJ 1995 Glucagon and its family revisited. Diabetes Care 18:715-730
9. Dunphy JL, Taylor RG, Fuller PJ 1998 Tissue distribution of rat glucagon receptor and GLP-1 receptor gene expression. Mol Cell Endocrinol 141:179-186 (Pubitemid 28393391)
10. Yamato E, Ikegami H, Takekawa K, Fujisawa T, Nakagawa Y, Hamada Y, Ueda H, Ogihara T 1997 Tissue-specific and glucose-dependent expression of receptor genes for glucagon and glucagon-like peptide-1 (GLP-1). Horm Metab Res 29:56-59 (Pubitemid 27170091)
11. Pilichiewicz AN, Chaikomin R, Brennan IM, Wishart JM, Rayner CK, Jones KL, Smout AJ, Horowitz M, Feinle-Bisset C 2007 Load-dependent effects of duodenal glucose on glycemia, gastrointestinal hormones, antropyloroduodenal motility, and energy intake in healthy men. Am J Physiol Endocrinol Metab 293:E743-E753 (Pubitemid 47358986)